Propanc Biopharma clears path for Phase 1b clinical study
Propanc Biopharma (PPCB) clears the path for a world-first Phase 1b clinical study of a cancer therapy, according to TradeXchange Newsdesk.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.